Suppr超能文献

使用酶联免疫吸附测定法测定小鼠体内抗体的全身药代动力学及组织间隙浓度的推导。

Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations.

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY, USA.

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY, USA.

出版信息

J Pharm Sci. 2021 Jan;110(1):446-457. doi: 10.1016/j.xphs.2020.05.025. Epub 2020 Jun 2.

Abstract

Here we have reported whole-body disposition of wild-type IgG and FcRn non-binding IgG in mice, determined using Enzyme-Linked Immunosorbent Assay (ELISA). The disposition data generated using ELISA are compared with previously published biodistribution data generated using radiolabelled IgG. In addition, we introduce a novel concept of ABC values, which are defined as percentage ratios of tissue interstitial and plasma AUC values. These values can help in predicting tissue interstitial concentrations of monoclonal antibodies (mAbs) based on the plasma concentrations. Tissue interstitial concentrations derived from our study are also compared with previously reported values measured using microdialysis or centrifugation method. Lastly, the new set of biodistribution data generated using ELISA are used to refine the PBPK model for mAbs.

摘要

在这里,我们使用酶联免疫吸附测定(ELISA)报告了野生型 IgG 和 FcRn 非结合 IgG 在小鼠体内的全身分布。使用 ELISA 生成的分布数据与先前使用放射性标记 IgG 生成的生物分布数据进行了比较。此外,我们引入了 ABC 值的新概念,它定义为组织间质和血浆 AUC 值的百分比比值。这些值可帮助根据血浆浓度预测单克隆抗体(mAb)的组织间质浓度。我们的研究中得出的组织间质浓度也与以前使用微透析或离心法测量的报告值进行了比较。最后,使用 ELISA 生成的新的生物分布数据集用于改进 mAb 的 PBPK 模型。

相似文献

2
Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.
J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):687-709. doi: 10.1007/s10928-007-9065-1. Epub 2007 Jul 18.
3
The effect of the neonatal Fc receptor on human IgG biodistribution in mice.
MAbs. 2014 Mar-Apr;6(2):502-8. doi: 10.4161/mabs.27765. Epub 2014 Jan 9.
4
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):67-86. doi: 10.1007/s10928-011-9232-2. Epub 2011 Dec 6.
5
Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
Mol Immunol. 2013 Dec;56(4):660-74. doi: 10.1016/j.molimm.2013.05.008. Epub 2013 Aug 2.
7
Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences.
Drug Metab Dispos. 2011 Sep;39(9):1469-77. doi: 10.1124/dmd.111.039453. Epub 2011 May 24.
9
Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies.
Pharm Res. 2022 Feb;39(2):239-250. doi: 10.1007/s11095-022-03177-2. Epub 2022 Feb 3.

引用本文的文献

1
A translational physiologically-based pharmacokinetic model for MMAE-based antibody-drug conjugates.
J Pharmacokinet Pharmacodyn. 2025 May 5;52(3):27. doi: 10.1007/s10928-025-09978-3.
3
PK/PD of Positively Charged ADC in Mice.
Pharmaceutics. 2025 Mar 17;17(3):377. doi: 10.3390/pharmaceutics17030377.
5
Versatile tissue-injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics.
Bioeng Transl Med. 2024 Apr 15;9(5):e10668. doi: 10.1002/btm2.10668. eCollection 2024 Sep.
6
8
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.
Biochim Biophys Acta Gen Subj. 2023 Nov;1867(11):130448. doi: 10.1016/j.bbagen.2023.130448. Epub 2023 Aug 29.
9
Clinical validation of translational antibody PBPK model using tissue distribution data generated with Zr-immuno-PET imaging.
J Pharmacokinet Pharmacodyn. 2023 Oct;50(5):377-394. doi: 10.1007/s10928-023-09869-5. Epub 2023 Jun 29.

本文引用的文献

1
Antibodies to watch in 2020.
MAbs. 2020 Jan-Dec;12(1):1703531. doi: 10.1080/19420862.2019.1703531.
2
A translational platform PBPK model for antibody disposition in the brain.
J Pharmacokinet Pharmacodyn. 2019 Aug;46(4):319-338. doi: 10.1007/s10928-019-09641-8. Epub 2019 May 21.
3
Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody-Drug Conjugate Via Fc-FcγR Interaction.
Mol Cancer Ther. 2019 Apr;18(4):780-787. doi: 10.1158/1535-7163.MCT-18-0977. Epub 2019 Mar 1.
4
FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues.
Biomolecules. 2018 Oct 15;8(4):115. doi: 10.3390/biom8040115.
6
Antibody pharmacokinetics in rat brain determined using microdialysis.
MAbs. 2018 Aug/Sep;10(6):843-853. doi: 10.1080/19420862.2018.1473910. Epub 2018 Aug 6.
7
Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models.
Cancer Res. 2018 Apr 1;78(7):1820-1832. doi: 10.1158/0008-5472.CAN-17-1958. Epub 2018 Jan 23.
9
Key considerations for LC-MS analysis of protein biotherapeutics in tissues.
Bioanalysis. 2017 Sep;9(18):1349-1352. doi: 10.4155/bio-2017-0122. Epub 2017 Sep 18.
10
Quantification of IgG monoclonal antibody clearance in tissues.
MAbs. 2017 Aug/Sep;9(6):1007-1015. doi: 10.1080/19420862.2017.1337619. Epub 2017 Jun 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验